Skip to content

A clinical study to see the effects on pulse and blood pressure during fusion spine surgery

To study the effect of neural manipulation on Haemodynamic Parameters during lumbar spine surgery in prone position. - No

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2014/09/004951
Enrollment
200
Registered
2014-09-01
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M498- Spondylopathy in diseases classified elsewhere Health Condition 2: null- Variation in Hemodynamic parameters during lumbar spine surgery

Interventions

Intervention1: Not Applicable: Not Applicable

Sponsors

Stavya Spine Hospital and Research Institute
Lead Sponsor
Stavya Spine Hospital and Research Institute
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patients are included in the study if all of the following criteria are met: 1.All the patient who were admitted in sshri and posted for single level Transforaminal Lumber Interbody Fusion for stenosis or disc surgery by principal investigator. 2.Skeletally mature adult between the ages of 30-70 years at the time of surgery; 3.Psychosocially, mentally and physically able to fully comply with this protocol and other study procedures; 4.Personally signed and dated informed consent document prior to any study-related procedures indicating that the patient has been informed of all pertinent aspects of the study.

Exclusion criteria

Exclusion criteria: Patients are excluded from participating in this study if any of the following criteria are met: 1.More than one (1) vertebral level to be fused; 2.Has had previous lumbar spine surgery 3.Patients with anemia (hemoglobin 4.Patients with Diffused Idiopathic Skeletal Hyperostosis (DISH); 5.Active systemic or local infection; 6.Known or documented history of communicable disease, including AIDS or HIV; 7.Active hepatitis (receiving medical treatment within two years); 8.Active rheumatoid arthritis, non-controlled diabetes mellitus, or any other medical condition(s) that would represent a significant increase in surgical risk or interfere with normal healing; 9.Immunologically suppressed, or has received systemic steroids, excluding nasal steroids, at any dose daily for > 1 month within last 12 months; 10.Known history of Pagetâ??s disease, osteomalacia, or any other metabolic bone disease; 11.Previous known allergy to the materials contained in the device, such as titanium alloy (TAN); 12.Morbid obesity defined as a body mass index > 40 kg/m2 or weight more than 100 pounds over ideal body weight; 13.Active malignancy. A patient with a history of any invasive malignancy (except non-melanoma skin cancer), unless treated with curative intent and there has been no clinical signs or symptoms of the malignancy for more than 5 years; 14.Current or recent history (within last 2 years) of substance abuse (e.g., recreational drugs, narcotics, or alcohol); 15.Pregnant or planning to become pregnant during study period; 16.Patients who have limited life expectancy due to significant medical comorbidities

Design outcomes

Primary

MeasureTime frame
Intraoperative Assessment of Hemodynamic ParametersTimepoint: During the surgical period of 2 hrs or 2 hrs( what ever it may be) at each step as mention

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDr Shaunak C Dudhia

Stavya Spine Hospital and Research Institute

drajaykrishnan@yahoo.co.in07926568174

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026